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Summary
Background and purpose: We assessed the usefulness of gated stress/rest 99mTc-
tetrofosmin myocardial perfusion single photon emission computed tomography
(SPECT) to predict ischemic cardiac events in Japanese patients with various esti-
mated pretest probabilities of coronary artery disease (CAD).
Methods and results: Of the 4031 consecutively registered patients for a J-ACCESS
(Japanese Assessment of Cardiac Events and Survival Study by Quantitative Gated
SPECT) study, 1904 patients without prior cardiac events were selected. Gated
stress/rest myocardial perfusion SPECT was performed and segmental perfusion
scores and quantitative gated SPECT results were derived. The pretest probability for
having CAD was estimated using the American College of Cardiology/American Heart
Association/American College of Physicians—American Society of Internal Medicine
guideline data for the management of patients with chronic stable angina, which
includes age, gender, and type of chest discomfort. The patients were followed up for
three years. During the three-year follow-up period, 96 developed ischemic cardiac
events: 17 cardiac deaths, 8 nonfatal myocardial infarction, and 71 clinically driven
∗ Corresponding author. Tel.: +81 948 223800; fax: +81 948 298747.
E-mail address: yimamurah2@aih-net.com (Y. Imamura).
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revascularization. The summed stress score (SSS) was the most powerful indepen-
dent predictor of all ischemic cardiac events (hazard ratio 1.077, CI 1.045—1.110).
Abnormal SSS (>3) was associated with a signiﬁcantly higher cardiac event rate in
patients with an intermediate to high pretest probability of CAD. Normal SSS (3)
was associated with a low event rate in patients with any pretest probability of CAD.
Conclusions: Myocardial perfusion SPECT is useful for further risk-stratiﬁcation of
patients with suspected CAD. The abnormal scan result (SSS > 3) is discriminative for
subsequent cardiac events only in the groups with an intermediate to high pretest
probability of CAD. The salient result is that normal scan results portend a benign
prognosis independent from the pretest probability of CAD.
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Introduction
In the evaluation of patients with suspected coro-
nary artery disease (CAD), the role of noninvasive
imaging has increased exponentially over the past
decade. The usefulness of stress/rest myocardial
perfusion single photon emission computed tomog-
raphy (SPECT) for the prediction of ischemic cardiac
events has been widely accepted [1—4]. Noninva-
sive evaluation of symptomatic patients to further
stratify risk beyond traditional risk factor scoring
has primarily relied on stress myocardial perfusion
imaging. But most of the data are of Western ori-
gin and existing data on the prognostic value of
SPECT ﬁndings in the Japanese population are still
scarce. The J-ACCESS (Japanese Assessment of Car-
diac Events and Survival Study) investigation is a
multicenter study to establish a Japanese database
of patients with known or suspected ischemic heart
disease by gated myocardial perfusion SPECT, and it
has been demonstrated that large myocardial per-
fusion defects and decreased cardiac function could
be predictors of cardiac events [5].
However, the estimated pretest probability of
having signiﬁcant CAD in a study population should
be taken into account in the evaluation of the diag-
nostic accuracy of myocardial perfusion SPECT to
detect or rule out the presence of CAD. Based on
the database from the J-ACCESS investigation, the
present study was designed to assess the usefulness
of gated stress/rest myocardial SPECT ﬁndings to
provide independent prognostic information for the
prediction of ischemic cardiac events in patients
with various pretest probabilities of CAD.
Subjects and methodsStudy population
The design, entry criteria, and protocol of the J-
ACCESS study have been published previously [6].
Brieﬂy, the entry criteria include: age 20 years
S
S
fCardiology. Published by Elsevier Ireland Ltd. All rights
r more, and scheduled to undergo stress/rest
lectrocardiogram (ECG)-gated SPECT due to sus-
ected or extant ischemic heart disease. Patients
ith the onset of myocardial infarction or unsta-
le angina pectoris within three months, valvular
eart disease, idiopathic cardiomyopathy, severe
rrhythmia, or heart failure with class III or
igher New York Heart Association (NYHA) classi-
cation, or severe liver or renal disorders were
xcluded. Among 4031 patients registered for the
-ACCESS study, patients with prior cardiac events,
yocardial infarction or previous history of angina
equiring percutaneous coronary intervention (PCI),
s well as coronary artery bypass grafting (CABG),
ere excluded. A total of 1904 patients without
rior cardiac events were selected for this analysis.
The pretest probability for having CAD was
stimated using the American College of Cardi-
logy/American Heart Association/American Col-
ege of Physicians—American Society of Internal
edicine (ACC/AHA/ACP—ASIM) guideline data for
he management of patients with chronic stable
ngina, which includes age, gender, and type of
hest discomfort [7]. Typical angina was deﬁned as
aving 3 characteristics: (1) substernal discomfort;
2) precipitated by physical exertion or emotions;
nd (3) relieved with rest or nitroglycerin. Atypical
ngina pectoris was deﬁned as having 2 of 3 of the
eﬁnition characteristics. Nonanginal chest pain
as characterized as having 1 or none of the def-
nition characteristics. Patients were categorized
nto a low probability (<0.15), intermediate prob-
bility (0.15—0.85), or high probability (>0.85) of
aving CAD. The institutional review board at each
f the involved hospitals approved the protocol of
he J-ACCESS study, and all patients gave writtenPECT imaging and stress ECG
tress/rest 99mTc-tetrofosmin SPECT was per-
ormed depending on the preference of each
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fisk stratiﬁcation using perfusion SPECT in coronary
nstitution. The exercise protocol or the pharma-
eutical method to induce stress was not specially
egulated. The imaging conditions and image pro-
essing procedures were surveyed separately [8].
he SPECT images were divided into 20 segments,
nd visual perfusion scores for 99mTc-tetrofosmin
ptake in individual segments were scored in ﬁve
tages as follows: 0, normal; 1, mildly reduced; 2,
oderately reduced; 3, severely reduced; and 4,
o uptake. All images were scored at the partic-
pating hospitals by hospital staff well-trained in
nterpretation and quantiﬁcation of typical SPECT
mages. The summed stress score (SSS) and summed
est score (SRS) were obtained by adding the scores
f the 20 segments of the respective images. The
ummed difference score (SDS) was deﬁned as the
ifference between SSS and SRS [9]. The SPECT
mages were considered normal when summed
cores were 0—3 and abnormal myocardial perfu-
ion defects was deﬁned as summed scores >3.
uantitative gated SPECT was performed at rest
nd the parameters of ejection fraction (%), end-
iastolic volume (EDV, mL), and end-systolic volume
ESV, mL) were calculated at each institution using
he same QGS software (Cedars Sinai Medical Cen-
er, Los Angeles, CA, USA) [10]. The agreement
f summed scores among participating hospitals
nd inter-institution reproducibility of gated SPECT
uantiﬁcation was good [11].
A 12-lead ECGwas recorded during the stress test
nd signiﬁcant ST-segment depression was deﬁned
s a >1mm of horizontal or downsloping depres-
c
h
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Table 1 Baseline characteristics of patients with and with
SRS, summed rest score; SDS, summed difference score; LVE
volume; and ESV, end-systolic volume. Data are presented as
between cardiac-event and event-free groups. NS means no
Cardiac event
96
Age 66.8± 9.4
Gender (male%) 68(71)
Body Mass Index 22.1± 3.4
Multiple risk factors (2) 51(53)
Diabetes mellitus 49(49)
Hypertension 56(58)
Hyperlipidemia 43(45)
Typical angina 29(30)
Positive ECG response 35(36)
SSS 9.9± 9.5
SRS 5.3± 7.0
SDS 4.5± 6.1
LVEF at rest (%) 58.2± 14.3
EDV at rest (mL) 94.6± 37.0
ESV at rest (mL) 43.3± 32.4ery disease 95
ion occurring at 80ms after the end of the QRS
omplex.
ollow-up data
ll patients underwent stress/rest myocardial per-
usion SPECT using 99mTc-tetrofosmin. Age, gender,
ubjective symptoms, history of present illness, the
mage data, and examinations other than SPECT
ere surveyed. The patients were followed up for
hree years thereafter. The outcome cardiac events
ecorded were cardiac death, nonfatal myocardial
nfarction, and clinically driven revascularization
surgery or angioplasty). Because referral to coro-
ary revascularization in the ﬁrst 60 days after
uclear testing tends to be based on the myocardial
erfusion scan results, late (>60 days after SPECT)
evascularization was chosen as a cardiac event. All
nformation on cardiac events was based on inves-
igator report forms.
tatistics
ontinuous variables are expressed as aver-
ges± SD. We applied the unpaired t-test to
ompare results from patients with and without
ardiac events, and the chi-square test was used
or categorical data.
The association of selected variables with out-
ome was assessed with the Cox proportional
azard model using univariate and stepwise mul-
ivariate procedures. The variables considered
out cardiac events. SSS indicates summed stress score;
F, left ventricular ejection fraction; EDV, end-diastolic
number (%) or mean value± SD. p-Values for comparison
t signiﬁcant.
Event-free p-Value
1808
64.2± 10.8 0.0240
934(52) 0.0004
23.4± 3.2 <0.0001
587(32) <0.0001
398(22) <0.0001
904(50) NS
832(46) NS
201(11) <0.0001
329(18) <0.0001
4.4± 6.5 <0.0001
3.3± 5.6 0.0050
1.2± 3.5 <0.0001
65.9± 11.9 <0.0001
77.4± 29.8 <0.0001
28.3± 21.8 <0.0001
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Table 2 Univariate prognostic predictors of cardiac events.
Wald chi-squared HR 95% CI p-Value
Age (75) 5.76 1.023 1.004—1.043 0.0164
Gender (male) 12.77 2.069 1.389—3.083 0.0004
Multiple risk factors (2) 14.81 2.063 1.427—2.983 0.0001
Typical angina 34.02 3.308 2.213—4.945 <0.0001
Positive ECG response 12.03 2.014 1.356—2.992 0.0005
SSS 62.31 1.066 1.049—1.083 <0.0001
SRS 17.84 1.046 1.024—1.068 <0.0001
SDS 58.42 1.111 1.081—1.141 <0.0001
LVEF at rest 20.78 0.970 0.958—0.983 <0.0001
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dial infarction) was only 0.4%/year. We includedEDV at rest 10.62
ESV at rest 14.46
included age, gender, presence of typical angina,
number of coronary risk factors (hypertension, dia-
betes mellitus, and hyperlipidemia), stress ECG
response, segmental perfusion scores, and QGS
parameters. A signiﬁcance of p < 0.05 was required
for a variable to be included into the multivariate
model. Hazard ratios with the corresponding 95%
conﬁdence intervals were estimated. Survival rates
were estimated with Kaplan—Meier curves and com-
pared by the log-rank test.
A p-value < 0.05 was considered statistically sig-
niﬁcant.
All statistical calculations were performed with
the Statistical Analysis System 9.1.3 (SAS Institute,
Cary, NC, USA) computer program.
Results
Patients’ characteristics and clinical
outcome
During the three-year follow-up period, 96 ischemic
cardiac events (17 cardiac deaths, 8 nonfatal
myocardial infarctions, and 71 clinically driven
revascularizations) were reported and used in the
analysis.
Table 1 details the baseline characteristics
of study patients stratiﬁed by clinical outcome.
l
p
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Table 3 Multivariate prognostic predictors of cardiac even
Wald chi-squared
Gender (male) 4.18
Multiple risk factors (2) 9.23
Typical angina 13.87
SSS 23.18
SRS 6.03
LVEF at rest 4.091.008 1.003—1.013 0.0011
1.010 1.005—1.015 0.0001
atients with cardiac events were older and exhib-
ted a higher prevalence of multiple risk factors,
ypical angina, and positive ECG response. The SSS,
RS, and SDS were signiﬁcantly higher in patients
ith cardiac events. Of the QGS values, LVEF was
ower, and EDV and ESV were larger in the cardiac
vent group.
utcome prediction
ox univariate prognostic indicators are exhibited
n Table 2. High age, male gender, multiple risk
actors, typical angina, positive ECG response, seg-
ental perfusion scores (SSS, SRS and SDS), and
he QGS parameters (LVEF, EDV and ESV) were
redictors of ischemic cardiac events. When Cox
ultivariate regression analysis was applied to
hese variables, SSS was the most powerful inde-
endent predictor of cardiac events, followed by
ypical angina, multiple risk factors, SRS, gender,
nd LVEF (Table 3). In the presents study, the hard
vents rate (cardiac death and nonfatal myocar-ate revascularization as cardiac events. But the
rognostic power of SSS was the same when only
he hard events were chosen as cardiac events
Wald chi-squared = 29.41, hazard ratio 1.039, CI
.013—1.108).
ts.
HR 95% CI p-Value
1.548 1.018—2.354 0.041
1.784 1.228—2.590 0.0024
2.303 1.485—3.574 0.0002
1.077 1.045—1.110 <0.0001
0.955 0.920—0.991 0.014
0.984 0.968—0.999 0.0431
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Figure 1 Cardiac event rate and pretest probability of
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patients with abnormal scan (SSS > 3) than in those
with normal scan (SSS 3) (Fig. 2). Fig. 3 shows the
cardiac event-free survival curves by SSS (SSS 3
versus SSS > 3) subgroups stratiﬁed by the pretest
probability of CAD (low, intermediate, high). In the
low probability of CAD group, the cardiac event
rates were similarly low in patients with SSS 3
and those with SSS > 3 (Fig. 3A). In the intermedi-AD. p < 0.01 for intermediate probability subgroup vs
ow probability subgroup, high probability subgroup vs
ow probability and intermediate probability subgroups,
espectively.
elationship between the cardiac event
ate and the pretest probability of CAD
ig. 1 depicts the relationship between the
schemic cardiac event rate and the pretest prob-
bility of CAD. The analysis comprised 532 (28%)
atients with low, 1160 (61%) patients with inter-
ediate, and 212 (11%) patients with high pretest
robability of CAD. Compared to the event rate in
atients with the low probability for CAD (event
ate = 6.7%), the event rate increased in patients
ith intermediate (event rate = 11.1% p < 0.001 ver-
us low probability group) to high probability of CAD
event rate = 19.3% p < 0.001 versus low and inter-
ediate probability groups).ardiac event rate and SSS
aplan—Meier survival analysis revealed that the
ardiac event rate was signiﬁcantly higher in
igure 2 Cardiac event-free curves in all patients
ccording to SSS (SSS > 3 versus SSS 3). Event-free sur-
ival rate was signiﬁcantly lower in patients with SSS > 3.
Figure 3 Cardiac event-free curves for each combina-
tion of pretest probability of CAD (low, intermediate,
high) and SSS (SSS > 3 versus SSS 3). In patients with low
probability of CAD (Panel A) both curves showed no signif-
icant difference. In patients with intermediate (Panel B)
and high (Panel C) probability of CAD, event-free survival
rate was signiﬁcantly lower in patients with SSS > 3.
98
Figure 4 Cardiac event-free curves according to the
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cations for the clinical use of SPECT imaging. Thatpretest probability of CAD in patients with normal perfu-
sion scan (SSS 3). The cardiac event rate was similarly
low independent from the pretest probability of CAD.
ate to high probability of CAD groups, the cardiac
event rate was signiﬁcantly higher in patients with
SSS > 3 than in those with SSS 3, and the patients
with high probability of CAD plus SSS > 3 had the
worst prognosis (Fig. 3B and C). Fig. 4 depicts the
cardiac event-free survival curves in patients with
normal perfusion scans (SSS 3). The cardiac event
rates were similarly low among patients with vari-
ous pretest probabilities of CAD and no divergence
of events was noted.
Discussion
The major ﬁndings of this study are that (1)
stress/rest 99mTc-tetrofosmin myocardial SPECT
imaging provides an independent and the best
prognostic information, especially in patients with
intermediate to high pretest probability of CAD,
and (2) normal myocardial perfusion scan results
are associated with a benign prognosis independent
from the pretest probability of CAD.
Segmental perfusion scores, especially SSS,
were related to a signiﬁcant increase in the risk
for ischemic cardiac events. The nature of the
99mTc-tetrofosmin abnormality that is prognosti-
cally important may depend on patient selection
and clinical end point. If most events are car-
diac death, the total perfusion abnormality (ﬁxed
and reversible) may be the most important pre-
dictor [12]. But if most endpoints are ischemic
cardiac events, reversible perfusion abnormality of
tetrofosmin may be the most important predictor.
In this study, the outcome events recorded were
mainly ischemic cardiac events including nonfatal
myocardial infarction, and late coronary revascu-
larization. Reversible perfusion defects can be a
sign of jeopardized myocardium that is at risk for
i
p
t
cY. Imamura et al.
uture ischemic events. Therefore, it is proper that
SS, which reﬂects both ﬁxed and reversible perfu-
ion abnormalities, is chosen as the best predictor.
he predictive power of SRS and SDS was less than
hat of SSS. It is because the participants selected
ere without prior cardiac events, which included
schemic events, and SRS was almost zero. There-
ore, the predictive power of SRS was weak. SDS
as deﬁned as difference between SSS and SRS and
he predictive value of SDS was included in that of
SS, and thus the predictive power of SDS was weak
ompared with that of SSS.
The extent of perfusion abnormality was the best
rognostic predictor of ischemic cardiac events.
atients with a large perfusion abnormality, SSS > 3,
ad a higher event rate than those with normal
erfusion scan (SSS 3). These results are con-
ordant with the multiple clinical studies showing
hat the major prognostic variables on stress per-
usion images predictive of future cardiac events
re a large defect size (>20% or >15% of the left
entricle), defects in >1 coronary vascular sup-
ly region, and defect reversibility reﬂective of
nducible ischemia in multiple myocardial scan
egments [13—15]. Furthermore, in the present
tudy, patients with intermediate to high proba-
ility of CAD could be further stratiﬁed by SSS
nto subgroups with low and high event rates.
hese observations suggest that myocardial perfu-
ion SPECT may be as accurate in patients with
ither intermediate to high pretest probability of
AD.
Importantly, this is the ﬁrst study showing that
ormal myocardial perfusion scan (SSS 3) is asso-
iated with good prognosis independent from the
retest probability of CAD in the Japanese pop-
lation. One of the most valuable features of
tress/rest myocardial perfusion imaging is its good
egative predictive value. Patients with normal
can at peak stress have a <1%/year combined mor-
ality and nonfatal infarction rate [16—18].
The prognostic value of 99mTc perfusion imag-
ng is comparable to that reported with 201Tl
maging. Normal stress 99mTc-sestamibi or 99mTc-
etrofosmin images were associated with an
verage annual hard event rate of 0.6—0.9%
19—21]. Berman et al. demonstrated that the car-
iac event rate for patients with normal scans was
ow for all levels of pretest likelihood of CAD after
he acquisition of exercise ECG stress test results
22]. These observations may have important impli-s, a noninvasive strategy for the assessment of
atients with suspected CAD may be safe and effec-
ive, thus avoiding unnecessary invasive cardiac
atheterization.
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Risk stratiﬁcation using perfusion SPECT in coronary
In the present study, among QGS parameters,
VEF at rest was associated with ischemic car-
iac events, but its predictive value was weak
ompared with SSS. Post-stress LVEF and volume
easured by quantitative gated SPECT have been
hown to be a highly predictive marker of cardiac
vents [23,24]. But QGS parameters in the current
tudy were determined at rest, not at peak stress,
nd the possibility of CAD cannot be excluded by
ormal left ventricular function at rest [25]. There-
ore, it is natural that the predictive power of
SS was superior to that of QGS parameters at
est.
tudy limitations
n this study, we used the ACC/AHA/ACP—ASIM
uideline data, which incorporate age, gender,
nd clinical presentation of chest pain, to esti-
ate the pretest probability of having CAD. Despite
his limitation, the incidence of ischemic car-
iac events correlated well with the estimated
retest probability of CAD. Thus, although the
CC/AHA/ACP—ASIM guideline data are of West-
rn origin, their data on pretest probability of
AD may be applicable to the Japanese popula-
ion.
linical implications
ur results demonstrate that stress/rest myocar-
ial perfusion SPECT imaging provides independent
rognostic information on future ischemic cardiac
vents in patients with an intermediate to high
retest probability of CAD. The salient result from
his trial is that a normal scan result (SSS 3) is
ssociated with a benign prognosis and is indepen-
ent from the pretest probability of CAD.
Recently, multi-slice computed tomography
MSCT) has been proposed as an alternative imaging
odality for evaluation of patients with sus-
ected CAD [26,27]. It is important to recognize,
owever, that myocardial perfusion imaging and
SCT provide complementary but different infor-
ation on CAD. The MSCT identiﬁes atherosclerosis
ather than ischemia and atherosclerosis is not
ynonymous with ischemia. Therefore, long-term
utcomes for patients may be determined by uti-
izing myocardial perfusion SPECT even when MSCT
ata are also available. The establishment of the
redictive accuracy of myocardial SPECT imaging
n a sufﬁciently large cohort of patients provides
ubstantial supportive evidence for its use in daily
linical decision making.ery disease 99
onclusions
PECT 99mTc-tetrofosmin imaging results provide
ndependent prognostic information for the predic-
ion of ischemic cardiac events and SSS can further
isk-stratify patients with intermediate to high esti-
ated pretest probability of CAD. The salient result
s that a normal scan portends a benign prognosis
ndependent from the pretest probability of CAD.
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